# A Disintegrin and Metalloprotease with Thrombospondin Motif, Member 13, and Von Willebrand Factor in Relation to the Duality of Preeclampsia and HIV Infection

**Authors:** Prelene Naidoo, Thajasvarie Naicker

PMC · DOI: 10.3390/ijms26094103 · 2025-04-25

## TL;DR

This paper explores how changes in VWF and ADAMTS13 during pregnancy and HIV infection affect blood clotting and inflammation.

## Contribution

The paper highlights the dual role of VWF and ADAMTS13 in preeclampsia and HIV-related thrombosis.

## Key findings

- VWF levels increase significantly during pregnancy, contributing to a hypercoagulable state.
- ADAMTS13 deficiency due to mutations or autoantibodies impairs VWF cleavage and increases thrombosis risk.
- HIV infection and SARS-CoV-2 trigger endothelial activation, leading to imbalanced VWF/ADAMTS13 ratios and thrombotic tendencies.

## Abstract

Normal pregnancy is associated with multiple changes in the coagulation and the fibrinolytic system. In contrast to a non-pregnant state, pregnancy is a hypercoagulable state where the level of VWF increases by 200–375%, affecting coagulation activity. Moreover, in this hypercoagulable state of pregnancy, preeclampsia is exacerbated. ADAMTS13 cleaves the bond between Tyr1605 and Met1606 in the A2 domain of VWF, thereby reducing its molecular weight. A deficiency of ADAMTS13 originates from mutations in gene or autoantibodies formed against the protease, leading to defective enzyme production. Von Willebrand protein is critical for hemostasis and thrombosis, promoting thrombus formation by mediating the adhesion of platelets and aggregation at high shear stress conditions within the vessel wall. Mutations in VWF disrupts multimer assembly, secretion and/or catabolism, thereby influencing bleeding. VWF is the primary regulator of plasma ADAMTS13 levels since even minute amounts of active ADAMTS13 protease have a significant inhibitory effect on inflammation and thrombosis. VWF is released as a result of endothelial activation brought on by HIV infection. The SARS-CoV-2 infection promotes circulating proinflammatory cytokines, increasing endothelial secretion of ultra large VWF that causes an imbalance in VWF/ADAMTS13. Raised VWF levels corresponds with greater platelet adhesiveness, promoting a thrombotic tendency in stenotic vessels, leading to increased shear stress conditions.

## Linked entities

- **Genes:** ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13) [NCBI Gene 11093], VWF (von Willebrand factor) [NCBI Gene 7450]
- **Proteins:** ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13)
- **Diseases:** preeclampsia (MONDO:0005081), HIV infection (MONDO:0005109)

## Full-text entities

- **Genes:** VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13) [NCBI Gene 11093] {aka ADAM-TS13, ADAMTS-13, C9orf8, VWFCP, vWF-CP}
- **Diseases:** coagulation (MESH:D001778), HIV Infection (MESH:D015658), SARS-CoV-2 (MESH:D000086382), Preeclampsia (MESH:D011225), thrombosis (MESH:D013927), bleeding (MESH:D006470), infection (MESH:D007239), inflammation (MESH:D007249), hypercoagulable (MESH:D019851), deficiency of ADAMTS13 (MESH:D007153)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12071684/full.md

---
Source: https://tomesphere.com/paper/PMC12071684